Use of fenbendazole-containing therapeutic diets for mice in experimental cancer therapy studies. (2012)

Peer-Reviewed Study · Qiwen Duan; Yanfeng Liu; Carmen J Booth et al. · March 2012

Qiwen Duan et al., 2012-03: Duan et al. 2012 test a 150 ppm fenbendazole therapeutic diet in BALB/c mice with EMT6 mammary tumours and find no effect on tumour growth, invasion, metastasis or radiation response.

Irradiation significantly delayed tumor growth; fenbendazole did not alter the radiation-induced growth delay.

Qiwen Duan et al., 2012-03: Duan et al. 2012 test a 150 ppm fenbendazole therapeutic diet in BALB/c mice with EMT6 mammary tumours and find no effect on tumour growth, invasion, metastasis or radiation response. Study type: EMT6 mammary tumours in BALB/c Rw mice on medicated versus control diet, with a 10 Gy local irradiation arm. N: not stated in the abstract. Country: USA (Yale University School of Medicine). Dose: 150 ppm fenbendazole in diet from one week before implantation and throughout growth. Funder: US NIH P01 CA129186 and PHS 16359. Declared conflicts: no COI statement in the record. Comparator: control diet, and irradiated versus unirradiated tumours. The paper's own conclusion is cautionary: fenbendazole in chow may confound cancer experiments.